Merck & Company, Inc. vs Veeva Systems Inc. — Stock Comparison
Merck & Company, Inc. (MRK) and Veeva Systems Inc. (VEEV) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Veeva Systems Inc. clearly outscores Merck & Company, Inc. on Q·Score (8.1 vs 6.3 out of 10), led by Quality (8.5 vs 4.9) and Health (9.7 vs 7). Merck & Company, Inc. scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst consensus targets imply greater upside for VEEV (+2.3%) than for MRK (-3.1%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
71% of 28 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
Clean balance sheet with low leverage (0.0× debt-to-equity).
Analyst Consensus
Fundamentals
Frequently Asked Questions
MRK vs VEEV: which stock scores better overall?
Based on Q·Score, Veeva Systems Inc. (VEEV) scores 8.1/10 versus Merck & Company, Inc. (MRK) at 6.3/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MRK or VEEV?
Veeva Systems Inc. (VEEV) scores higher on Growth (8.6/10 vs 6.4/10). Merck & Company, Inc. reports revenue growth (5.1% YoY) while Veeva Systems Inc. reports (16.3% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MRK or VEEV more attractively valued?
Merck & Company, Inc. (MRK) scores higher on Valuation (6.5/10 vs 6/10). MRK trades at 16.0× P/E versus VEEV at 24.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MRK vs VEEV?
There are 26 analysts covering MRK with a consensus price target of $147.77, and 28 analysts covering VEEV with a consensus target of $253.57. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MRK or VEEV?
Veeva Systems Inc. (VEEV) scores higher on Quality (8.5/10 vs 4.9/10). Net profit margin: MRK at 4.8%, VEEV at 28.4%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MRK or VEEV?
Veeva Systems Inc. (VEEV) scores higher on Financial Health (9.7/10 vs 7/10). Market beta: MRK at 0.21, VEEV at 0.92. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MRK and VEEV?
Merck & Company, Inc. (MRK) has a market capitalisation of $376.4B, while Veeva Systems Inc. (VEEV) has a market cap of $40.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MRK or VEEV pay dividends?
MRK pays a dividend yield of 2.23%, while VEEV does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →